Document:

<PAGE>   1
                                                                    Exhibit 10.1

                       THIRD AMENDMENT TO PROMISSORY NOTE

     THIRD AMENDMENT TO PROMISSORY NOTE dated as of the 12th day of November,
2000 by and between RAYMOND C. KUBACKI, JR. ( "Kubacki") and PSYCHEMEDICS
CORPORATION (the "Company").

     WHEREAS, Kubacki and the Company entered into a Promissory Note dated
November 12, 1997, (the "Note") in the original principal amount of Two Hundred
Eleven Thousand Two Hundred Thirty-two Dollars ($211,232.00); and

     WHEREAS, the due date of the Note was extended pursuant to a First
Amendment to the Note dated November 12, 1998 and a Second Amendment to the Note
dated November 12, 1999; and

     WHEREAS, the principal amount and accrued interest outstanding as of the
date hereof under the Note, as amended, is $197,318.58; and

     WHEREAS, Kubacki's obligations under the Note as amended are secured by a
pledge of shares of Common Stock of the Company pursuant to a Pledge Agreement
dated November 12, 1997 (the "Pledge Agreement");

     NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereto hereby agree as follows:

     1. AMENDMENT. (a) The Note as previously amended, is hereby further amended
by deleting the first three paragraphs thereof and inserting in lieu thereof the
following:

          "FOR VALUE RECEIVED, the undersigned RAYMOND C. KUBACKI, JR. hereby
     promises to pay to the order of PSYCHEMEDICS CORPORATION, a Delaware
     corporation (the "Company"), in accordance with and subject to the terms
     and conditions set forth herein, on or before November 12, 2001, the
     principal sum of ONE HUNDRED NINETY-SEVEN THOUSAND THREE HUNDRED EIGHTEEN
     AND 58/100 DOLLARS ($197,318.58), or so much thereof as may from time to
     time be outstanding, and to pay interest on the unpaid portion of such
     principal amount at the rate of 6.40% PER ANNUM until such principal amount
     and all accrued unpaid interest thereon shall have been paid.

          Interest accrued on the unpaid balance of principal from time to time
     outstanding shall be payable together with payment of principal. Each
     payment made under this Note shall be applied first to interest then due
     and then to principal.

          This Note is secured by a pledge of certain shares of Common Stock of
     the Company owned by the undersigned more particularly described in the
     Pledge Agreement dated November 12, 1997 (the "Pledge Agreement") by and
     between the undersigned and the Company. The Pledge Agreement is intended
     to provide additional security to the Company for the obligations of the
     undersigned under this Note and is not intended to limit in any way the
     obligations of the undersigned under this Note which is a full recourse
     obligation of the undersigned."

                                       1
<PAGE>   2

     (b) All references in the Pledge Agreement to the Note shall be deemed to
refer to the Note, as modified and amended hereby.

     2. RATIFICATION. (a) The terms and provisions of the Note, as modified and
amended hereby, are hereby ratified and confirmed by Kubacki in all respects and
the Note shall remain in full force and effect in accordance with its terms as
so modified and amended.

     (b) The obligations of Kubacki to repay to the Company all indebtedness
under the Note, as modified and amended hereby, and to pay and perform all of
its other obligations to the Company are and will continue to be secured by the
Pledge Agreement and the Company is and will continue to be entitled to the
benefit of all of the rights and remedies thereunder.

     (c) Nothing herein is intended or shall be construed so as to discharge,
release, terminate, or otherwise limit or modify any indebtedness, obligations,
or liabilities of Kubacki or any collateral security therefor.

     3. MISCELLANEOUS. This Third Amendment to Promissory Note shall be governed
by the laws of the Commonwealth of Massachusetts, shall be construed as a sealed
instrument, and shall be binding upon, and inure to the benefit of, the parties
hereto and their respective successors and assigns.

     Executed as a sealed instrument as of the date set forth above.

                                        PSYCHEMEDICS CORPORATION

                                        By: /s/ Peter C. Monson
                                            -----------------------------
                                            Peter Monson, Vice President

                                            /s/ Raymond C. Kubacki, Jr
                                            -----------------------------
                                            Raymond C. Kubacki, Jr.

                                       2<PAGE>   1
                                                                    Exhibit 10.2

                       FOURTH AMENDMENT TO PROMISSORY NOTE

     FOURTH AMENDMENT TO PROMISSORY NOTE dated as of the 6th day of January,
2001 by and between RAYMOND C. KUBACKI, JR. ("Kubacki") and PSYCHEMEDICS
CORPORATION (the "Company").

     WHEREAS, Kubacki and the Company entered into a Promissory Note dated
January 6, 1997, (the "Note") in the original principal amount of Two Hundred
Nine Thousand Eight Hundred Ninety-two Dollars ($209,892.00); and

     WHEREAS, the due date of the Note was extended pursuant to a First
Amendment to the Note dated January 6, 1998, a Second Amendment to the Note
dated January 6, 1999 and a Third Amendment to the Note dated January 6, 2000;
and

     WHEREAS, the principal amount and accrued interest outstanding as of the
date hereof under the Note, as amended, is $193,431.33; and

     WHEREAS, Kubacki's obligations under the Note as amended are secured by a
pledge of shares of Common Stock of the Company pursuant to a Pledge Agreement
dated January 6, 1997 (the "Pledge Agreement");

     NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereto hereby agree as follows:

     1. AMENDMENT. (a) The Note as previously amended is hereby further amended
by deleting the first three paragraphs thereof and inserting in lieu thereof the
following:

          "FOR VALUE RECEIVED, the undersigned RAYMOND C. KUBACKI, JR. hereby
     promises to pay to the order of PSYCHEMEDICS CORPORATION, a Delaware
     corporation (the "Company"), in accordance with and subject to the terms
     and conditions set forth herein, on or before January 6, 2002, the
     principal sum of ONE HUNDRED NINETY-THREE THOUSAND FOUR HUNDRED THIRTY-ONE
     DOLLARS AND 33/100 ($193,431.33), or so much thereof as may from time to
     time be outstanding, and to pay interest on the unpaid portion of such
     principal amount at the rate of 6.15% PER ANNUM until such principal amount
     and all accrued unpaid interest thereon shall have been paid.

          Interest accrued on the unpaid balance of principal from time to time
     outstanding shall be payable together with payment of principal. Each
     payment made under this Note shall be applied first to interest then due
     and then to principal.

          This Note is secured by a pledge of certain shares of Common Stock of
     the Company owned by the undersigned more particularly described in the
     Pledge Agreement dated January 6, 1997 (the "Pledge Agreement") by and
     between the undersigned and the Company. The Pledge Agreement is intended
     to provide additional security to the Company for the obligations of the
     undersigned under this Note and is not intended to limit in any way the
     obligations of the undersigned under this Note which is a full recourse
     obligation of the undersigned."
<PAGE>   2

     (b) All references in the Pledge Agreement to the Note shall be deemed to
refer to the Note, as modified and amended hereby.

     2. RATIFICATION. (a) The terms and provisions of the Note, as modified and
amended hereby, are hereby ratified and confirmed by Kubacki in all respects and
the Note shall remain in full force and effect in accordance with its terms as
so modified and amended.

     (b) The obligations of Kubacki to repay to the Company all indebtedness
under the Note, as modified and amended hereby, and to pay and perform all of
its other obligations to the Company are and will continue to be secured by the
Pledge Agreement and the Company is and will continue to be entitled to the
benefit of all of the rights and remedies thereunder.

     (c) Nothing herein is intended or shall be construed so as to discharge,
release, terminate, or otherwise limit or modify any indebtedness, obligations,
or liabilities of Kubacki or any collateral security therefor.

     3. MISCELLANEOUS. This Fourth Amendment to Promissory Note shall be
governed by the laws of the Commonwealth of Massachusetts, shall be construed as
a sealed instrument, and shall be binding upon, and inure to the benefit of, the
parties hereto and their respective successors and assigns.

     Executed as a sealed instrument as of the date set forth above.

                                            PSYCHEMEDICS CORPORATION

                                            By: /s/ Peter C. Monson
                                                ---------------------------
                                                Peter Monson, Vice President

                                                /s/ Raymond C. Kubacki, Jr
                                                ---------------------------
                                                Raymond C. Kubacki, Jr.<PAGE>   1
                                                                   Exhibit 10.13

(isotbvyncgowan)

                             STOCK OPTION AGREEMENT

     Agreement (the "Option Agreement") dated this 7th Day of February 2001
(the "Date of Grant"), between Infinium Software, Inc., a Massachusetts
corporation (the "Company"), and James E. McGowan, Social Security No.
###-##-#### (the "Participant") an employee of the Company with a residence
address at 34463 Foxwood Lane, Bluemont, Virginia 20135.

     1.   Grant of Option. The Company hereby grants to the Participant an
option to purchase, in whole or in part and from time to time, on the terms
herein provided, a total of 700,000 shares of common stock of the Company
("Common Stock") at $1.75 per share, which is not less than the fair market
value of the Common Stock on the date hereof. This option is granted pursuant
to and subject to the provisions of the Company's 1995 Stock Plan, as amended
(the "Plan") attached hereto as Exhibit A. Capitalized terms used herein but
not defined herein have the meanings given them in the Plan.

     2.   Time Limits. Except as otherwise provided in this Section, in Section
6 hereof (relating to the death of the Participant), in Section 7 hereof
(relating to the disability of the Participant) and in Section 8 hereof
(relating to other termination of employment of the Participant), and subject to
the provisions of subparagraph C of paragraph 8 of the Plan (relating to the
minimum number of shares exercisable at any one time), this option is
exercisable as follows:

     (a)  Regular Vesting.
          The Option shall vest at twenty percent (20%) per year (or 140,000
          options per year) on each of the five anniversaries of the Date of
          Grant.

     (b)  Accelerated Vesting.

          1. If the price of the Company's Common Stock remains above $8.00 per
          share, daily, for 3 consecutive months, then the 140,000 options from
          the fifth anniversary will be accelerated to the next business day
          following the end of the 3-month period.

          2. If the price of the Company's Common Stock remains above $10.00
          per share, daily, for 3 consecutive months, then the 140,000 options
          from the fifth anniversary (if not previously accelerated) and the
          140,000 options from the fourth anniversary will be accelerated to the
          next business day following the end of the 3-month period.

All of the Executive's unvested stock options shall vest immediately upon the
occurrence of a Change in Control (as defined in the attached Exhibit B.)

This option may not be exercised to any extent after the expiration of six
years from the Date of Grant.

     3.   Exercise of Option. This option (or any part or installment hereof)
shall be exercised by giving written notice to the Company at its principal
office address, or to such transfer agent as the Company shall designate. Such
notice shall identify the option agreement under which the option is being
exercised and specify the number of shares as to which the option is being
exercised, accompanied by full payment of the purchase price therefor. It is
intended that this option shall be an incentive stock option ("ISO") as defined
in Section 422 of the Internal Revenue Code of 1986, as amended from time to
time (the "Code"), to the extent permitted by the Code. However, to the extent
that

                                                                               1
<PAGE>   2
the Participant may accrue the right to exercise options which are intended to
be ISOs as defined in the Code (whether pursuant to this Option Agreement or
pursuant to any other stock option agreement between the Participant and the
Company or any Related Corporation) in any calendar year with an aggregate fair
market value in excess of $100,000 (determined as of the option grant date),
such options in excess of the $100,000 limitation shall be treated as
nonqualified stock options not subject to the provisions of Section 422 of the
Code.

     4. Payment for and Delivery of Stock. The shares of Common Stock purchased
upon any exercise of this option shall be paid for in full at the time of such
exercise. The option price may be paid either (a) in United States dollars in
cash or by check, (b) through delivery of shares of Common Stock having a fair
market value equal as of the date of the exercise equal to the cash exercise
price of the option, (c) at the discretion of the Committee, by delivery of the
Participant's personal recourse note bearing interest payable not less than
annually at no less than 100% of the lowest applicable federal rate, as defined
in Section 127(d) of the Code, (d) consistent with applicable law, through the
delivery of an assignment to the Company of a sufficient amount of the proceeds
from the sale of the Common Stock acquired upon exercise of the option and an
authorization to the broker or selling agent to pay that amount to the Company,
which sale shall be at the Participant's direction at the time of exercise, or
(e) at the discretion of the Committee, by any combination of (a), (b), (c) and
(d) above. If the price is paid in whole or in part in Common Stock, such Common
Stock shall be valued at the fair market value at the time of exercise, as
determined by the Committee, in determining the extent to which the option price
has been paid in Common Stock.

     5. Non-transferability of Option. This option may not be transferred by the
Participant otherwise than by will, by the laws of descent and distribution or,
in the case of Non-Qualified Options only, pursuant to a valid domestic
relations order. Except as set forth in the previous sentence, during the
lifetime of the Participant this option may be exercised only by him or her.

     6. Death. If the Participant ceases to be employed by the Company and all
Related Corporations by reason of his or her death, then, effective on such
date, all of the Participant's unvested stock options in the Company will become
immediately vested and this option may be exercised by the estate, personal
representative or beneficiary who has acquired the ISO by will or by the laws of
descent and distribution, until the earlier of (i) the specified expiration date
of the ISO or (ii) 180 days from the date of the Participant's death.

     7. Disability. If the Participant ceases to be employed by the Company and
all Related Corporations by reason of his or her disability, the Participant
shall have the right to exercise any ISO held by him or her hereunder on the
date of termination of employment, for the number of shares for which he or she
could have exercised it on that date, until the earlier of (i) the specified
expiration date of the ISO or (ii) 180 days from the date of the termination of
the Participant's employment. For the purposes of this Agreement, the term
"disability" shall mean "permanent and total disability as defined in Section
22(e) of the Code.

     8. Termination of Employment. (a) If the employment of the Participant
terminates for any reason other than "cause", then this option shall expire on
the earlier of (i) ninety (90) days after the date of termination of employment
or (ii) six years from the Date of Grant. For purposes of this Agreement,
"cause" is defined as: substantial and continued failure to perform job duties;
disloyalty, gross negligence, or breach of fiduciary duty to the Company;
commission of a fraud, embezzlement, dishonesty or deliberate disregard of the
Company's rules or policies; unauthorized disclosure of a trade secret or
confidential business information; use of any illicit drug or the abuse of any
drug, alcohol or medication which adversely affects the Participant's job
performance; or conviction of a felony offense.

                                                                               2
<PAGE>   3
     (b)  If such termination of employment is for cause, this option may be
exercised following such termination of employment only to the extent, if any,
approved by the Committee.

Transfer from the employ of the Company to the employ of a Related Corporation,
from the employ of a Related Corporation to the employ of the Company, or from
the employ of one Related Corporation to the employ of another Related
Corporation, or a leave of absence granted by the Company or a Related
Corporation as set forth in the Plan shall not be deemed a termination of
employment for purposes of this option.

     9.   Changes in Stock. In the event of a stock dividend, stock split or
other change in corporate structure or capitalization affecting the Common
Stock, the Committee shall make appropriate adjustments in (i) the number and
kind of shares of stock remaining subject to the option at the time of such
change and (ii) the option price. The Committee's determination shall be
binding on all persons concerned. If the Company is to be consolidated with or
acquired by another entity in a merger or other reorganization in which the
holders of the outstanding voting stock of the Company immediately preceding
the consummation of such event, shall, immediately following such event, hold,
as a group, less than a majority of the voting securities of the surviving or
successor entity, or in the event of a sale of all or substantially all of the
Company's assets or otherwise (each, an "Acquisition"), the Committee or the
board of directors of an entity assuming the obligations of the Company
hereunder (the "Successor Board"), shall, as to the option, either (i) make
appropriate provision for the continuation of the option by substituting on an
equitable basis for the shares then subject to the option either (a) the
consideration payable with respect to the outstanding shares of Common Stock in
connection with the Acquisition, (b) shares of stock of the surviving or
successor corporation or (c) such other securities as the Successor Board deems
appropriate, the fair market value of which shall not materially exceed the
fair market value of the shares of Common Stock subject to the option
immediately preceding the Acquisition; or (ii) upon written notice to the
Participant, provided that the options shall be exercised, to the extent then
exercisable or to be exercisable as a result of the Acquisition, within a
specified number of days of the date of such notice, at the end of which period
the option shall terminate; or (iii) terminate the option in exchange for a
cash payment equal to the excess of the Fair Market Value of the shares subject
to the option (to the extent then exercisable or to be exercisable as a result
of the Acquisition) over the exercise price thereof.

     10.  Reservation of Shares. The Company shall at all times during the term
of the option granted hereby reserve and keep available such number of shares
of the Common Stock as will be sufficient to satisfy the requirements of the
option granted hereby.

     11.  Restrictions on Disposition. All shares acquired by the Participant
pursuant to the option granted hereby shall be subject to all restrictions set
forth in the Company's by-laws and in any applicable agreements between or
among the Participant, other shareholders and/or the Company. In addition, the
Participant hereby agrees that all shares acquired pursuant to the option
granted hereby, regardless of when acquired, may not be pledged, sold, assigned
or in any other manner transferred, except with the prior written consent of
the Company (such consent being in the sole discretion of the Company), and
shall continue to be held by the Participant, or, in the case of the
Participant's death, by his executor or administrator or the person or persons
to whom the option or the shares acquired pursuant to the option was/were
transferred by will or the applicable laws of descent and distribution, for a
minimum period extending until the earlier to occur of (a) the end of the six
month period succeeding the completion of an initial public offering of
securities of the Company or (b) the end of the two year period succeeding the
later to occur of (i) the date of Participant's termination of employment with
the Company or any of its subsidiaries or affiliates or (ii) the date on which
such shares are acquired pursuant to this option. In addition, the Participant
acknowledges his understanding that he will be disqualified under Section 422
of the Code from receiving the favorable income tax treatment otherwise
available

                                                                               3
<PAGE>   4
with respect to the exercise of an Incentive Stock Option if he makes a
Disqualifying Disposition of any Common Stock received by exercising this
option. The Participant hereby agrees to notify the Company in writing within
one month after he makes a Disqualifying Disposition of any Common Stock
received pursuant to the exercise of this option. "Disqualifying Disposition"
means any disposition (including any sale) of such stock prior to the
Participant's death before the later of (a) two years after the Participant was
granted this option under which he acquired such stock, or (b) one year after
the Participant acquired such stock by exercising this option.

     12.  NO RIGHT TO EMPLOYMENT. The grant of this option does not confer upon
the Participant any right to continued employment with the Company, nor does it
interfere in any way with the right of the Company to terminate the employment
of the Participant at any time.

     13.  COMMUNICATIONS. Any communication or notice required or permitted to
be given under this Agreement shall be delivered in hand, if to the Company, to
its Secretary at 25 Communications Way, Independence Park, Hyannis, MA 02601,
and, if to the Participant, at the address set forth on the first page of this
Agreement or such other address, in each case, as the addressee shall last have
furnished to the communicating party.

     14.  MISCELLANEOUS. This option granted hereunder (a) is intended to
satisfy the requirements of Section 422 of the Code and the authorities
promulgated hereunder and shall be construed accordingly, and (b) shall be
construed under and governed by the laws of the Commonwealth of Massachusetts.

     IN WITNESS WHEREOF, Infinium Software, Inc. has caused this Agreement to
be executed by its duly authorized officer and the Participant has hereunto set
his hand, both as of the Date of Grant set forth above.

INFINIUM SOFTWARE, INC.                      PARTICIPANT

By: /s/ Robert A. Pemberton                  By: /s/ James E. McGowan
   -------------------------------              --------------------------------

                                             Print Name: James E. McGowan
                                                        ------------------------

                                                                               4
<PAGE>   5

February 7, 2001

Mr. James McGowan
Irish Mist Farm
34463 Foxwood Lane
Bluemont, VA 20

Dear Jim:

It is with great  pleasure that I extend an invitation to you to join our senior
management team as Chief  Executive  Officer,  President and,  subject to and in
accordance with Infinium's By-Laws, a Director (the "Executive").

I    BASE SALARY AND GENERAL BENEFITS

a)   Infinium  Software Inc. (the "Company")  shall pay to the Executive  during
his employment with the Company a salary (the "Annual Base Salary") based upon a
per annum rate of three hundred and twenty five thousand dollars ($325,000). The
Annual  Base  Salary  shall be  payable  in  periodic  equal  installments  on a
semi-monthly basis, or otherwise as paid to executives in the Company generally.

b)   During the Executive's employment with the Company, and to the extent
commensurate with the Executive's  level of  responsibility  within the Company,
the Executive shall be entitled to participate in such pension,  profit sharing,
bonus or incentive  compensation,  incentive,  group and individual  disability,
group and individual life, survivor income, sickness,  accident, dental, medical
and health  benefits  and other  benefit  plans of the  Company,  or  additional
benefit programs which may be established by the Company,  for its United States
executive officers; provided however, throughout the Executive's employment, the
Executive  shall be entitled to not less than four (4) weeks of annual  vacation
and the Executive shall be entitled to leave of absence and leave for illness or
temporary  disability in  accordance  with the policies of the Company in effect
from time to time for its executive officers or, if more generous, the policy in
effect for its employees generally.  A summary of the Company's current benefits
for United  States  employees is enclosed  with this letter.  In addition to the
benefits  described in the enclosed  summary,  a financial  planning  benefit is
currently available to executive officers.

c)   The  Company  shall  reimburse  the  Executive  from  time to time  for all
reasonable and customary business expenses incurred by him in the performance of
his duties  hereunder,  provided  that the Executive  shall submit  vouchers and
other  supporting data to substantiate the amount of said expenses in accordance
with Company policy from time to time in effect.

d)   Vacation  leave and leave of absence,  if taken by the  Executive  shall be
taken at such times as are  reasonably  acceptable to the Company.  Any leave on
account of illness or temporary  disability which is short of Total  Disability,
shall not constitute a breach by the Executive of his agreements  hereunder even
though  leave on  account  of a Total  Disability  may be  deemed to result in a
termination  of the Employment  Period under the  applicable  provisions of this
Agreement.

e)   If the Company  purchases and maintains at any time during the  Executive's
employment one or more life insurance policies on the life of the Executive,  in
whatever amount or amounts the Company deems desirable, the Company shall be the
beneficiary  of such policy or policies and the Executive  shall  cooperate with
the Company and submit to such reasonable medical  examinations as are necessary
to enable the  Company to  purchase  and  maintain in full force and effect such
additional insurance policy or policies.

f)   Throughout the employment period, the Company shall pay to the Executive an
automobile allowance equal to $750 per month. This amount will be paid monthly.

--------------------------------------------------------------------------------
Confidential                       Page 1                       February 7, 2001

<PAGE>   6

II.  STOCK OPTIONS

The Executive shall receive a stock option grant, under the Company's 1995 Stock
Plan,  pursuant to the terms of a stock option  agreement in  substantially  the
form attached as Exhibit A to this letter and as otherwise  described below. The
stock  option  agreement  shall  provide for the  issuance to the  Executive  of
options to acquire 700,000 shares of the Company's common stock.

Vesting Schedule:

A.   Regular  Vesting.  The  Option  shall be  vested in the  amount of  140,000
options shares per year subject to the Option on each of five  anniversaries  of
the Grant Date.

B.   Accelerated Vesting.

     1.   If the stock  price  remains  above  $8.00  per  share,  daily,  for 3
          consecutive months then the 140,000 options from the fifth anniversary
          will be  accelerated to the next business day following the end of the
          3-month period.

     2.   If the stock  price  remains  above  $10.00  per share,  daily,  for 3
          consecutive months then the 140,000 options from the fifth anniversary
          (if not  previously  accelerated)  and the  140,000  options  from the
          fourth  anniversary  will be  accelerated  to the  next  business  day
          following the end of the 3-month period.

III. EXECUTIVE BONUS

The Executive will be eligible to earn a bonus based on the Company's attainment
of goals set by the Board of Directors.  The Company expects that the goals will
be set by the Board within thirty days of the Executive's  employment start date
and, for each fiscal year thereafter, within thirty days following the inception
of the fiscal year.  If the Executive  achieves the goals set by the Board,  the
Executive will earn a TARGET EXECUTIVE BONUS in the amounts indicated below:

         FISCAL YEAR 2001                                     $132,000

         FISCAL YEAR 2002                                     $200,000

         FISCAL YEAR 2003                                     $245,000

         FISCAL YEAR 2004                                     $245,000.

In the event the  Executive  exceeds  the  goals  set by the  Board,  he will be
entitled to a bonus in excess of the TARGET EXECUTIVE BONUS. Further information
regarding  the bonus in each fiscal  year,  including  the manner of earning the
bonus,  the timing of payments  and the over  achievement  calculation,  will be
included in the Executive's  written Incentive  Compensation Plan from the Board
of Directors.

IV.  TERMINATION

If the Executive's employment with the Company is terminated by the Company, not
for "cause",  and the Executive resigns from the Board of Directors and executes
a one year Non-Competition and  Non-Solicitation  Agreement in form satisfactory
to the Company,  (a) the Company will continue to pay to the Executive,  for the
eighteen month period beginning on the termination  date, his Annual Base Salary
and the  Target  Executive  Bonus,  if any,  due  during  the period and (b) the
Executive  will be entitled to continue to  participate  in all of the Company's
employee  benefits  programs (except to the extent  prohibited by the plans) for
the eighteen month period  beginning on the termination  date. In the event that
such termination is, in the judgment of the Board,  primarily connected with the
living  location of the Executive  then,  following  reasonable  notice from the
Board to the  Executive  and an  opportunity  to cure

--------------------------------------------------------------------------------
Confidential                       Page 2                       February 7, 2001

<PAGE>   7

the location  issue,  the  18-month  provision  for ANNUAL BASE  SALARY,  TARGET
EXECUTIVE BONUS and for benefits above will be reduced to 12 months.

If (a) the Executive is  terminated  in connection  with a Change in Control (as
defined in Exhibit B to this letter), or (b) following a Change in Control,  the
Executive is removed from his offices (as Chief Executive Officer, President and
Director), then for a period equal to twelve months from the date of termination
(i) the Company will continue to pay to the Executive his ANNUAL BASE SALARY and
the TARGET EXECUTIVE BONUS, if any, due during the period and (ii) the Executive
will be entitled to continue to  participate  in all of the  Company's  employee
benefits programs (except to the extent prohibited by the plans) for the period.
In  addition,   all  of  the  Executive's  unvested  stock  options  shall  vest
immediately upon the occurrence of a Change in Control.

For  purposes of this  agreement,  "cause" is defined as follows  failure of the
Executive  to devote his full  business  time and efforts to the business of the
Company;  disloyalty,  gross  negligence,  or  breach of  fiduciary  duty to the
Company;  commission of fraud, embezzlement,  dishonesty or deliberate disregard
of the Company's rules or policies; unauthorized disclosure of a trade secret or
confidential business  information;  use of any illicit drug or the abuse of any
drug, alcohol or medication which adversely affects the Executive's performance;
or conviction of a felony offense.

V.   CONFIDENTIALITY

The  Executive  will  be  bound  by the  terms  of the  Proprietary  Information
Agreement attached as Exhibit C to this letter.

VI.  OTHER

It  is  agreed  that,   although  the  Executive  will  be  located  in  Eastern
Massachusetts,  he will retain his principal residence in Northern Virginia.  He
will also establish a Company office in Northern Virginia. His principal support
group will continue to be provided from the Company's  headquarters  in Hyannis,
Massachusetts until the Board of Directors grants permission for a change.

Subject  to  the  Executive's  execution  and  return  of  this  letter  to  the
undersigned,  the Executive's  employment  will begin on Wednesday,  February 7,
2001.

The  Executive's  employment  at the  Company is  "at-will"  in that  either the
Executive or the Company has the right to terminate the employment  relationship
at any time with or without cause subject to the termination provisions above.

INFINIUM SOFTWARE, INC.

/s/ Robert A. Pemberton
-----------------------------------
Robert A. Pemberton, CEO

The offer of employment contained herein is hereby accepted,  and I agree to the
terms of such offer.  I also affirm that my  acceptance  of this offer is not in
conflict with any other employment agreement to which I am a party.

Signature: James E. McGowan
           -------------------------
James E. McGowan

Date: 14 Feb 01

--------------------------------------------------------------------------------
Confidential                       Page 3                       February 7, 2001

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00025-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00025-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00025-of-00352.parquet"}]]